NSN 6505-01-660-4989 · NIIN 016604989 · FSC 6505
NO DASHES 6505016604989
In Stock
CHLORDIAZEPOXIDE HYDROCHLORIDE C
Drugs and Biologicals
Technical characteristics
10 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | POWDER |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT 5.0 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LIBRIUM (CHLORDIAZEPOXIDE HCL) 5 MG CAPSULE, 100S |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| FEAT | SPECIAL FEATURES | EACH CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE CONTAINS 5 MILLIGRAMS (MG) OF THE ACTIVE INGREDIENT; PACKAGED IN BOTTLES OF 100 CAPSULES; DEA SCHEDULE DRUG CLASS IV; STORE AT 20 TO 25 C (68 TO 77 F); (SEE USP CONTROLLED ROOM TEMPERATURE) |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| AJCN | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.0 |
| CSGS | ADMINISTRATION | ORAL |
Cross-references
3 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC00555-0158-02 | 3V8D7 |
| 6505NCM163281 | 64616 |
| 1445365 | 89875 |